WallStreetZenWallStreetZen

NASDAQ: APRE
Aprea Therapeutics Inc Stock Ownership - Who owns Aprea Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aprea Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Oren GiladPresidentCEO2025-04-033,003$1.87
$5.62kBuy
Oren GiladPresidentCEO2025-04-032,497$1.80
$4.49kBuy
Oren GiladPresidentCEO2024-10-23500$3.92
$1.96kBuy
Marc DueyDirector2024-10-186,462$4.58
$29.58kSell
Marc DueyDirector2024-10-1630,000$4.39
$131.70kBuy
Oren GiladPresidentCEO2024-10-15250$2.90
$725.00Buy
Marc DueyDirector2024-10-14190$2.58
$490.20Buy
Oren GiladPresidentCEO2024-10-141,000$2.59
$2.59kBuy
John P. HamillSrVPCFOPrin Fin Acct Ofcr2024-10-1150$2.46
$123.20Buy
Bernd R. SeizingerDirector2024-10-1110,000$2.68
$26.80kBuy

1 of 2

APRE insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APRE insiders and whales buy or sell their stock.

APRE Shareholders

What type of owners hold Aprea Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Tryant LLC506.20%28,000,000$51.52MInsider
Thomas Banks242.09%13,391,146$24.64MInsider
Frank J. Hall86.45%4,781,889$8.80MInsider
David West Wilson52.88%2,924,726$5.38MInsider
Heidi A. Patterson48.60%2,688,221$4.95MInsider
Kdev Investments Ab36.02%1,992,586$3.67MInsider
Michael Reynolds35.80%1,980,040$3.64MInsider
Redmile Group LLC31.98%1,768,718$3.25MInsider
Aigh Capital Management LLC9.75%539,300$992.31kInstitution
Oren Gilad6.28%347,420$639.25kInsider

1 of 3

APRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APRE3.18%96.82%Net BuyingNet Buying
PSTV1.19%71.44%Net Buying
GLYC30.41%69.59%Net Selling
AEON5.29%94.71%Net BuyingNet Buying
CYCN11.60%88.40%Net SellingNet Buying
View Top Biotech Stocks

Aprea Therapeutics Stock Ownership FAQ

Who owns Aprea Therapeutics?

Aprea Therapeutics (NASDAQ: APRE) is owned by 35.25% institutional shareholders, 1,073.76% Aprea Therapeutics insiders, and 0.00% retail investors. Tryant LLC is the largest individual Aprea Therapeutics shareholder, owning 28.00M shares representing 506.20% of the company. Tryant LLC's Aprea Therapeutics shares are currently valued at $51.52M.

If you're new to stock investing, here's how to buy Aprea Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.